West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Sei Investments Co.

Sei Investments Co. raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 12.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 401,026 shares of the medical instruments supplier’s stock after purchasing an additional 45,208 shares during the quarter. Sei Investments Co. owned about 0.55% of West Pharmaceutical Services worth $132,095,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in WST. Pacer Advisors Inc. increased its position in shares of West Pharmaceutical Services by 17.9% in the 2nd quarter. Pacer Advisors Inc. now owns 8,574 shares of the medical instruments supplier’s stock valued at $2,824,000 after acquiring an additional 1,303 shares during the period. Skandinaviska Enskilda Banken AB publ increased its holdings in shares of West Pharmaceutical Services by 9.8% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 15,629 shares of the medical instruments supplier’s stock valued at $5,148,000 after purchasing an additional 1,401 shares during the period. Bridges Investment Management Inc. purchased a new position in shares of West Pharmaceutical Services in the second quarter worth about $205,000. Canada Pension Plan Investment Board lifted its holdings in shares of West Pharmaceutical Services by 25.0% during the second quarter. Canada Pension Plan Investment Board now owns 207,564 shares of the medical instruments supplier’s stock worth $68,370,000 after purchasing an additional 41,454 shares during the period. Finally, Davidson Capital Management Inc. boosted its position in West Pharmaceutical Services by 34.1% in the second quarter. Davidson Capital Management Inc. now owns 8,926 shares of the medical instruments supplier’s stock valued at $2,940,000 after buying an additional 2,272 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Price Performance

Shares of NYSE:WST opened at $308.15 on Friday. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The company has a market cap of $22.45 billion, a PE ratio of 40.65, a price-to-earnings-growth ratio of 10.58 and a beta of 1.01. The company’s 50 day moving average is $303.67 and its 200 day moving average is $337.77.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business had revenue of $702.10 million for the quarter, compared to analysts’ expectations of $729.36 million. During the same period last year, the business earned $2.11 EPS. The company’s revenue for the quarter was down 6.9% on a year-over-year basis. On average, sell-side analysts forecast that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insider Activity

In related news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the sale, the vice president now directly owns 1,478 shares of the company’s stock, valued at $443,400. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.